Neuroendocrine and metabolic effects of adipocyte-derived hormones

Clinical Science

Volumn 110, Issue 2, 2006, Pages 143-152

  Jackson, Malaka B ^a   Ahima, Rexford S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adiponectin; Adipose tissue; Hypothalamus; Leptin; Neuropeptide; Resistin

Indexed keywords

CORTICOSTEROID; CYTOKINE; GLUCOSE; LEPTIN; LIPID; RESISTIN;

ADIPOCYTE; ADIPOSE TISSUE; BLOOD CLOTTING; CARDIOVASCULAR SYSTEM; CORTICOSTEROID RELEASE; ENERGY; ENERGY BALANCE; HEMODYNAMICS; HOMEOSTASIS; HORMONE ACTION; HUMAN; IMMUNE SYSTEM; METABOLISM; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW;

ADIPOCYTES; HOMEOSTASIS; HORMONES; HUMANS; INFLAMMATION; INSULIN RESISTANCE; NEUROSECRETORY SYSTEMS; OBESITY;

EID: 32644432147     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050243     Document Type: Review

References (105)

1. Ahima, R. S. (2000) Leptin and the neuroendocrinology of fasting. Front. Horm. Res. 26, 42-56
2. Hausman, G. J. and Richardson, R. L. (2004) Adipose tissue angiogenesis. J. Anim. Sci. 82, 925-934
3. Rupnick, M. A., Panigrahy, D., Zhang, C. Y. et al. (2002) Adipose tissue mass can be regulated through the vasculature. Proc. Natl. Acad. Sci. U.S.A. 99, 10730-10735
4. Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R. and Arap, W. (2004) Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 10, 625-632
5. Trayhurn, P. and Wood, I. S. (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 92, 347-355
6. Xu, H., Barnes, G. T., Yang, Q. et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830
7. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L. and Ferrante, Jr, A. W. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808
8. Flier, J. S. (2004) Obesity wars: molecular progress confronts an expanding epidemic. Cell 116, 337-350
9. Kennedy, G. C. (1953) The role of depot fat in the hypothalamic control of food intake in the rat. Proc. R. Soc. Lond. B. Biol. Sci. 140, 578-596
10. Ingalls, A. M., Dickie, M. M. and Snell, G. D. (1950) Obese, a new mutation in the house mouse. J. Hered. 41, 317-318
11. Coleman, D. L. and Hummel, K. P. (1969) Effects of parabiosis of normal with genetically diabetic mice. Am. J. Physiol. 217, 1298-1304
12. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. and Friedman, J. M. (1994) Positional cloning of the mouse ob gene and its human homologue. Nature (London) 372, 425-432
13. Erratum (1995) Nature (London) 374, 479
14. Friedman, J. (1998) Leptin and the regulation of body weight in mammals. Nature (London) 395, 763-770
15. Ahima, R. S., Saper, C. B., Flier, J. S. and Elmquist, J. K. (2000) Leptin regulation of neuroendocrine systems. From. Neuroendocrinol. 21, 263-307
16. Licinio, J., Mantzoros, C., Negrao, A. B. et al. (1997) Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat. Med. 3, 575-579
17. Ahima, R. S., Prabakaran, D., Mantzoros, C. et al. (1996) Role of leptin in the neuroendocrine response to tasting. Nature (London) 382, 250-252
18. Licinio, J., Negrao, A. B., Mantzoros, C. et al. (1998) Sex differences in circulating human leptin pulse amplitude: clinical implications. J. Clin. Endocrinol. Metab. 83, 4140-4147
19. Tartaglia, L. A. (1997) The leptin receptor. J. Biol. Chem. 272, 6093-6096
20. Bjorbaek, C., Uotani, S., da Silva, B. and Flier, J. S. (1997) Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 272, 32686-32695
21. Bjorbaek, C., Buchholz, R. M., Davis, S. M. et al. (2001) Divergent roles of SHP-2 in ERK activation by leptin receptors. J. Biol. Chem. 276, 4747-4755
22. Myers, Jr, M. G. (2004) Leptin receptor signaling and regulation of mammalian physiology. Recent Prog. Horm. Res. 59, 287-304
23. Xu, A. W., Kaelin, C. B., Takeda, K., Akira, S., Schwartz, M. W. and Barsh, G. S. (2005) PI3K integrates the action of insulin and leptin on hypothalamic neurons. J. Clin. Invest. 115, 951-958
24. Cohen, P., Zhao, C., Cai, X. et al. (2001) Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest. 108, 1113-1121
25. Gao, Q., Wolfgang, M. J., Neschen, S. et al. (2004) Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc. Natl. Acad. Sci. U.S.A. 101, 4661-4666
26. Bates, S. H., Stearns, W. H., Dundon, T. A. et al. (2003) STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature (London) 421, 856-859
27. Balthasar, N., Coppari, R., McMinn, J. et al. (2004) Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42, 983-991
28. Howard, J. K., Cave, B. J., Oksanen, L. J., Tzameli, I., Bjorbaek, C. and Flier, J. S. (2004) Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3, Nat. Med. 10, 734-738
29. Mori, H., Hanada, R., Hanada, T. et al. (2004) Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat. Med. 10, 739-743
30. Farooqi, I. S., Jebb, S. A., Langmack, G. et al. (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341, 879-884
31. Ozata, M., Ozdemir, I. C. and Licinio, J. (1999) Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J. Clin. Endocrinol. Metab. 84, 3686-3695.
32. Erratum (2000) J. Clin. Endocrinol. Metab. 85, 416
33. Farooqi, I. S., Keogh, J. M., Kamath, S. et al. (2001) Partial leptin deficiency and human adiposity. Nature (London) 414, 34-35
34. Chan, J. L., Heist, K., DePaoli, A. M., Veldhuis, J. D. and Mantzoros, C. S. (2003) The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J. Clin. Invest. 111, 1409-1421
35. Welt, C. K., Chan, J. L., Bullen, J. et al. (2004) Recombinant human leptin in women with hypothalamic amenorrhea. N. Engl. J. Med. 351, 987-997
36. Schurgin, S., Canavan, B., Koutkia, P., Depaoli, A. M. and Grinspoon, S. (2004) Endocrine and metabolic effects of physiologic r-metHuLeptin administration during acute caloric deprivation in normal-weight women. J. Clin. Endocrinol. Metab. 89, 5402-5409
37. Musso, C., Cochran, E., Javor, E., Young, J., Depaoli, A.M. and Gorden, P. (2005) The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients. Metab., Clin. Exp. 54, 255-263
38. Javor, E. D., Cochran, E. K., Musso, C., Young, J. R., Depaoli, A. M. and Gorden, P. (2005) Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 4, 1994-2002
39. McDuffie, J. R., Riggs, P. A., Calis, K. A. et al. (2004) Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency. J. Clin. Endocrinol. Metab. 89, 4258-4263
40. Guo, L., Munzberg, H., Stuart, R. C., Nillni, E. A. and Bjorbaek, C. (2004) N-acetylation of hypothalamic alpha-melanocyte-stimulating hormone and regulation by leptin. Proc. Natl. Acad. Sci. U.S.A. 101, 11797-11802
41. Legradi, G., Emerson, C. H., Ahima, R. S., Flier, J. S. and Lechan, R. M. (1997) Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 138, 2569-2576
42. Ahima, R. S., Bjorbaek, C., Osei, S. and Flier, J. S. (1999) Regulation of neuronal and glial proteins by leptin: implications for brain development. Endocrinology 140, 2755-2762
43. Bouret, S. G., Draper, S. J. and Simerly, R. B. (2004) Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304, 108-110
44. Matochik, J. A., London, E. D., Yildiz, B. O. et al. (2005) Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J. Clin. Endocrinol. Metab. 90, 2851-2854
45. Pinto, S., Roseberry, A. G., Liu, H. et al. (2004) Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304, 110-115
46. Ahima, R. S., Kelly, J., Elmquist, J. K. and Flier, J. S. (1999) Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 140, 4923-4931
47. Banks, W. A. and Farrell, C. L. (2003) Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. Am. J. Physiol. Endocrinol. Metab. 285, E10-E15
48. Zabolotny, J. M., Bence-Hanulec, K. K., Stricker-Krongrad, A. et al. (2002) PTP1B regulates leptin signal transduction in vivo. Dev. Cell. 2, 489-495
49. Schwartz, M. W., Woods, S. C., Seeley, R. J., Barsh, G. S., Baskin, D. G. and Leibel, R. L. (2003) Is the energy homeostasis system inherently biased toward weight gain? Diabetes 52, 232-238
50. Chehab, F. F., Lim, M. E. and Lu, R. (1996) Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat. Genet. 12, 318-320
51. Heiman, M. L., Ahima, R. S., Craft, L. S., Schoner, B., Stephens, T. W. and Flier, J. S. (1997) Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 138, 3859-3863
52. Quintela, M., Senaris, R., Heiman, M. L., Casanueva, F. F. and Dieguez, C. (1997) Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels. Endocrinology 138, 5641-5644
53. Clement, K., Vaisse, C., Lahlou, N. et al. (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature (London) 392, 398-401
54. Berg, A. H., Combs, T. P. and Scherer, P. E. (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13, 84-89
55. Bouskila, M., Pajvani, U. B. and Scherer, P. E. (2005) Adiponectin: a relevant player in PPARγ-agonist-mediated improvements in hepatic insulin sensitivity? Int. J. Obes. Relat. Metab. Disord. 29 (Suppl. 1), S17-S23
56. Maeda, N., Shimomura, I., Kishida, K. et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8, 731-737
57. Berg, A. H., Combs, T. P., Du, X., Brownlee, M. and Scherer, P. E. (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947-953
58. Yamauchi, T., Kamon, J., Waki, H. et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941-946
59. Yamauchi, T., Kamon, J., Ito, Y. et al. (2004) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature (London) 423, 762-769
60. Erratum (2004) Nature (London) 431-1123
61. Kadowaki, T. and Yamauchi, T. (2005) Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439-451
62. Shklyaev, S., Aslanidi, G., Tennant, M. et al. (2003) Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc. Natl. Acad. Sci. U.S.A. 100, 14217-14222
63. Tomas, E., Tsao, T. S., Saha, A. K. et al. (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U.S.A. 99, 16309-16313
64. Fruebis, J., Tsao, T. S., Javorschi, S. et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U.S.A. 98, 2005-2010
65. Qi, Y., Takahashi, N., Hileman, S. M. et al. (2004) Adiponectin acts in the brain to decrease body weight. Nat Med. 10, 524-529
66. Erratum (2004) Nat. Med. 10, 649
67. Steppan, C. M., Bailey, S. T., Bhat, S. et al. (2001) The hormone resistin links obesity to diabetes. Nature (London) 409, 307-312
68. Steppan, C. M., Brown, E. J., Wright, C. M. et al. (2001) A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. U.S.A. 98, 502-506
69. Savage, D. B., Sewter, C. P., Klenk, E. S. et al. (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 50, 2199-2202
70. Patel, S. D., Rajala, M. W., Rossetti, L., Scherer, P. E. and Shapiro, L. (2004) Disulfide-dependent multimeric assembly of resistin family hormones. Science 304, 1154-1158
71. Satoh, H., Nguyen, M. T., Miles, P. D., Imamura, T., Usui, I. and Olefsky, J. M. (2004) Adenovirus-mediated chronic 'hyper-resistinemia' leads to in vivo insulin resistance in normal rats. J. Clin. Invest. 114, 224-231
72. Rangwala, S. M., Rich, A. S., Rhoades, B. et al. (2004) Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53, 1937-1941
73. Banerjee, R. R., Rangwala, S. M., Shapiro, J. S. et al. (2004) Regulation of tasted blood glucose by resistin. Science 303, 1195-1198
74. Muse, E. D., Obici, S., Bhanot, S. et al. (2004) Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 114, 232-239
75. Steppan, C. M., Wang, J., Whiteman, E. L., Birnbaum, M. J. and Lazar, M. A. (2005) Activation of SOCS-3 by resistin. Mol. Cell. Biol. 25, 1569-15675
76. Stumvoll, M. and Haring, U. (2002) Resistin and adiponectin-of mice and men. Obes. Res. 10, 1197-1199
77. Azuma, K., Oguchi, S., Matsubara, Y. et al. (2004) Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm. Metab. Res. 36, 564-570
78. Bouchard, L., Weisnagel, S. J., Engert, J. C. et al. (2004) Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Quebec Family Study. J. Endocrinol. Invest. 27, 1003-1009
79. McTernan, P. G., Fisher, F. M., Valsamakis, G. et al. (2003) Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J. Clin. Endocrinol. Metab. 88, 6098-6106
80. Ohmori, R., Momiyama, Y., Kato, R. et al. (2005) Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J. Am. Coll. Cardiol. 46, 379-380
81. 76a Kusminski, C. M., McTernan, P. G. and Kumar, S. (2005) Role of resistin in obesity, insulin resistance and Type II diabetes. Clin. Sci. 109, 243-256
82. Silswal, N., Singh, A. K., Aruna, B., Mukhopadhyay, S., Ghosh, S. and Ehtesham, N. Z. (2005) Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway. Biochem. Biophys. Res. Commun. 334, 1092-1101
83. Reilly, M. P., Lehrke, M., Wolfe, M. L., Rohatgi, A., Lazar, M. A. and Rader, D. J. (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111, 932-939
84. Lehrke, M., Reilly, M. P., Millington, S. C., Iqbal, N., Rader, D. J. and Lazar, M. A. (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 1, e45
85. Rajala, M. W., Qi, Y., Patel, H. R. et al. (2004) Regulation of resistin expression and circulating levels in obesity, diabetes, and tasting. Diabetes 53, 1671-1679
86. Kim, K. H., Lee, K., Moon, Y. S. and Sul, H. S. (2001) A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J. Biol. Chem. 276, 11252-11256
87. Kim, K. H., Zhao, L., Moon, Y., Kang, C. and Sul, H. S. (2004) Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc. Natl. Acad. Sci. U.S.A. 101, 6780-6785
88. Belanger, C., Luu-The, V., Dupont, P. and Techernof, A. (2002) Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm. Metab. Res. 34, 737-745
89. Meseguer, A., Puche, C. and Cabero, A. (2002) Sex steroid biosynthesis in white adipose tissue. Horm. Metab. Res. 34, 731-736
90. Jones, M. E., Thorburn, A. W., Britt, K. L. et al. (2001) Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J. Steroid Biochem. Mol. Biol. 79, 3-9
91. Jones, M. E., Thorburn, A. W., Britt, K. L. et al. (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. U.S.A. 97, 12735-12740
92. Takeda, K., Toda, K., Saibara, T. et al. (2003) Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J. Endocrinol. 176, 237-246
93. Simpson, E. R., Misso, M., Hewitt, K. N. et al. (2005) Estrogen-the good, the bad, and the unexpected. Endocr. Rev. 26, 322-330
94. Seckl, J. R. (2004) 11β-Hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr. Opin. Pharmacol. 4, 597-602
95. Masuzaki, H., Paterson, J., Shinyama, H. et al. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166-2170
96. Masuzaki, H., Yamamoto, H., Kenyon, C. J. et al. (2003) Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J. Clin. Invest. 112, 83-90
97. Morton, N. M., Holmes, M. C., Fievet, C. et al. (2001) Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J. Biol. Chem. 276, 41293-41300
98. Morton, N. M., Paterson, J. M., Masuzaki, H. et al. (2004) Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53, 931-938
99. Draper, N., Echwald, S. M., Lavery, G. G. et al. (2002) Association studies between microsatellite markers within the gene encoding human 11β-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J. Clin. Endocrinol. Metab. 87, 4984-4990
100. Draper, N. and Stewart, P. M. (2005) 11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J. Endocrinol. 186, 251-271
101. Fukuhara, A., Matsuda, M., Nishizawa, M. et al. (2005) Vistatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426-430
102. Hug, C. and Lodish, H. K (2005) Vistatin: a new adipokine. Science 307, 366-367
103. Hida, K., Wada, J., Eguchi, J. Y. S. et al. (2005) Visceral adipose tissue derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. Proc. Natl. Acad. Sci. U.S.A. 102, 10610-10615
104. Yang, Q., Graham, T. E., Mody, N. et al. (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature (London) 436, 356-362
105. Christensen, E. I., Moskaug, J. O., Vorum, H. et al. (1999) Evidence for an essential role of megalin in transepithelial transport of retinol. J. Am. Soc. Nephrol. 10, 685-695